How did FNA's Q4 2024 EPS forecast compare to past trends?

**Paragon 28's (FNA) Q4 2024 EPS forecast is not currently available**, and thus cannot be directly compared to past trends. However, we can analyze the company's historical EPS trends using the available data. 1. **No Data on Q4 2024 EPS Forecast**: Currently, there are no available data or forecasts for FNA's Q4 2024 EPS. 2. **Historical EPS Trends**: According to the available data, FNA's EPS has not shown a consistent trend over the past few years. For instance, the EPS diluted TTM CAGR for FNA has been 0% over the past 10 years, indicating a stagnant period for the company's earnings. 3. **Recent Performance**: In Q3 2024, FNA reported an EPS of $-0.15, which is a negative result, but it surpassed analysts' expectations by $0.01. This indicates that while the company has improved in terms of revenue and profitability, it still has a long way to go to achieve positive EPS. 4. **Future Outlook**: The company is expected to continue growing, with a projected revenue growth rate of 14% per annum over the next three years, compared to the 8.3% growth rate of the Medical Equipment industry in the US. This suggests that while FNA's EPS may not have followed a consistent trend recently, it could be on the path to improvement due to strategic growth initiatives and market expansion. In conclusion, FNA's Q4 2024 EPS forecast is not currently available for comparison to past trends. However, the available data indicates a recent negative EPS result, but with signs of improvement and positive growth potential in the future.